Year-end Report 2018 / 2019
Oasmia will hold an audiocast and telephone conference on Friday 28 June at 09:00 (CET) to present the company’s full-year report for the financial year 2018/2019 and the status of the board’s previously communicated review of the company.
Investor meeting in Stockholm
Date: November 25 2019 Time: 18.00‒19.00 Location: Clarion Hotel Sign, Östra Järnvägsgatan 35, Stockholm Registration: [email protected] (no later than on Friday 22 November)
Investor meeting in Gothenburg
Date: November 27 2019 Time: 18.00‒19.00 Location: Clarion Hotel Post, Drottningtorget 10, Göteborg Registration: [email protected] (no later than on Friday 22 November)
41st EORTC-PAMM Winter Meeting in Stockholm
Oasmia was one of the official sponsors of the exciting 41st EORTC-PAMM Winter Meeting in Stockholm.
Avanza Börsdag
On 3 June 2020 Oasmia Pharmaceutical’s CEO Francois Martelet will present at Avanza’s Digitala Börsdag. The presentation starts at 9:05 am CET and will be broadcasted live as a webcast...
Oasmia to present at Aktiespararna’s Småbolagsdagar
On 10 June 2020 Oasmia Pharmaceutical’s CEO Francois Martelet will present at Aktiespararna’s Småbolagsdagar. The presentation starts at 15:30 CET and will be broadcast live as a webcast at:...
Aktiedagen Stockholm
Oasmia Pharmaceutical’s CEO, Dr Francois Martelet will present at Aktiespararna’s Aktiedagen Stockholm on September 7, 2021. The presentation starts at 10:30 CEST and will be broadcast live as a...
Live-streamed R&D update regarding Paccal Vet
Vivesto will hold a live-streamed R&D Update on March 26 at 14:00 CET, focusing on the veterinary oncology product Paccal Vet and the company's ongoing open clinical pilot study. Vivesto recently...
Vivesto to attend BIO-Europe
Vivesto's CEO Erik Kinnman will attend Europe's largest biopartnering meeting BIO-Europe on November 4-6, this year held in Stockholm. Read more here For more information, please contact: Erik...